Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Boesen Biotech ApS
APS
Active
CVR 39142635
Lipkesgade 25, 2100
København Ø
Activities of holding companies
·
NACE 6421
Est. 2017 · 8 years old
— employees
Monitor
Share
Denmark
/
Companies
/
Activities of holding companies
/
Boesen Biotech ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2020
0M
0%
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
Income statement
DKK thousands
Item
2020
2021
2022
2023
2024
Gross profit
-21
-34
-36
-28
-21
Staff expenses
-0
-0
-0
-0
-0
EBITDA
-21
-34
-36
-28
-21
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
-21
-34
-36
-28
-21
Net financials
2.845
10.381
-5.426
-3.974
717
Profit before tax
2.823
10.348
-5.463
-4.002
696
Tax
514
2.267
-0
-35
-28
Net profit
2.309
8.081
-5.463
-3.967
724
Balance sheet
DKK thousands
Item
2020
2021
2022
2023
2024
Total assets
6.697
16.233
11.109
5.394
6.062
Equity
2.082
10.163
4.700
733
1.457
Long-term debt
4.086
3.789
6.270
4.407
4.586
Short-term debt
528
2.281
139
254
19
Total debt
4.614
6.070
6.409
4.661
4.605
Financial ratios
5-year trend
EBITDA margin (of gross profit)
-2106600.0%
This company
2020
2024
Equity ratio
24.0%
This company
38.2%
Market median
-37% vs market
2020
2024
Return on equity
49.7%
This company
18.4%
Market median
+170% vs market
2020
2024
Net profit margin (of gross profit)
72381200.0%
This company
2020
2024
Asset turnover (of gross profit)
-0.00×
This company
2020
2024
Debt / equity
3.16×
This company
0.62×
Market median
-410% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
View
PDF
More on Boesen Biotech ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
